Intraepithelial Gamma/delta T Cells in Duodenal Mucosa Are Related to the Immune State and Survival Time in AIDS
Overview
Affiliations
The proportion of T-cell receptor gamma/delta+ cells and the CD4/CD8 ratio relative to all CD3+ intraepithelial lymphocytes (IEL) were determined by immunofluorescence in duodenal mucosa of late-stage (mostly CDC IVC1/D) subjects (n = 21) infected with human immunodeficiency virus type 1 (HIV-1). The gamma/delta fraction (median, 14.2%; range, 1.7 to 59.8%) was increased (P < 0.03) compared with that in HIV- controls (n = 11; median 2.8%; range, 0.3 to 38%). Also, the number of gamma/delta+ IEL per mucosal unit was increased (P < 0.05) in the HIV+ subjects (median, 11.1/U) compared with the controls (3.2/U). Approximately 100% of the gamma/delta+ IEL were CD8-, and most expressed the Vdelta1vJdelta1-encoded epitope (median, 90.9%). The total number of CD3+ IEL tended to be lower than in the controls (67.4 versus 72.9/U). Both the epithelium and the lamina propria contained mainly CD8+ T cells, the median ratios of CD4+ T cells being 1 and 7.6%, respectively. This result accorded with the reduced CD4 cell number in blood (median, 18 X 10(6)/liter). The HIV+ subjects had increased serum levels of neopterin and beta2-microglobulin (both P < 0.0001), probably reflecting immunostimulation. Serum neopterin and beta2-microglobulin were inversely related to duodenal gamma/delta IEL, particularly in the premortal group (r = -0.97 and r = -0.58, respectively). The increased gamma/delta IEL might reflect enhanced intestinal protection in late-phase HIV infection. Short survival expectancy (<7 months) was associated not only with high levels of neopterin and beta2-microglobulin but also with a reduced number of duodenal gamma/delta+ cells (P < 0.03).
Kozan E, Kirmizi B, Kirsaclioglu C, Gokmen D, Savas B, Kansu A Histopathology. 2024; 86(3):397-409.
PMID: 39375308 PMC: 11707493. DOI: 10.1111/his.15330.
Gut Innate Immunity and HIV Pathogenesis.
Dillon S, Wilson C Curr HIV/AIDS Rep. 2021; 18(2):128-138.
PMID: 33687703 PMC: 10472818. DOI: 10.1007/s11904-021-00544-3.
Biradar S, Lotze M, Mailliard R Viruses. 2020; 12(12).
PMID: 33348583 PMC: 7766279. DOI: 10.3390/v12121455.
Mucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond.
Shacklett B Curr Immunol Rev. 2019; 15(1):63-75.
PMID: 31327960 PMC: 6640863. DOI: 10.2174/1573395514666180528081204.
γδ T-cell responses during HIV infection and antiretroviral therapy.
Juno J, Eriksson E Clin Transl Immunology. 2019; 8(7):e01069.
PMID: 31321033 PMC: 6636517. DOI: 10.1002/cti2.1069.